MDMA therapy for PTSD reaches FDA MAPS Public Benefit Corporation submitted MDMA as a new drug application, making its approval more likely Salon · Dec 14, 2023
15 Global Psychedelics Executives To Keep An Eye On In 2022 As the global psychedelics industry booms, with companies going public, major financings being announced, and celebrities and big investors getting on board, Benzinga has decided to put together a list of some of the top executives in the space to keep an eye on. Benzinga · Oct 28, 2022
10 Psychedelics CEOs To Pay Attention To In 2022 By Javier Hasse and Aaron Bry. 2020 and 2021 were defining years for the burgeoning psychedelics industry. In 2021 alone, more than $730 million were invested into various psychedelic companies, both private and public. Benzinga · Jun 22, 2022
Former Moderna Vice President Joins Psychedelics Company In Phase 3 Trials For Ecstasy Michael Mullette, a former Moderna (NASDAQ:MNRA) vice president is taking a senior leadership position in the MAPS Public Benefit Corporation, a biotech company in the psychedelics sector. The MAPS PCB is a for-profit company wholly owned by the Multidisciplinary Association for Psychedelic Studies, a nonprofit founded in 1986 to advance patient… Benzinga · Mar 8, 2022